Division of AIDS, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Clinic and Research Center of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai.
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):663-668. doi: 10.5588/ijtld.18.0323.
China has been playing an increasingly important role in global health in recent decades. Substantial progress and reform has been made in the country's health care system, but China still hosts one third of the world's diabetes mellitus (DM) patients and one fifth of the world's tuberculosis (TB) patients. Recent economic and public health advancements have provided tools for new drug development and facilitated the implementation of novel strategies. However, a unique set of challenges exist, including regulatory barriers, ethical concerns and the lack of a unified system and approaches across disease areas. This article analyses the current disease situation in China and discusses China's potential role in the global battle against the TB and DM co-epidemic.
近几十年来，中国在全球卫生领域发挥着越来越重要的作用。中国的医疗保健系统取得了实质性的进步和改革，但中国仍有三分之一的糖尿病患者和五分之一的结核病患者。最近的经济和公共卫生进步为新药开发提供了工具，并促进了新策略的实施。然而，中国还存在一系列独特的挑战，包括监管障碍、伦理问题以及疾病领域缺乏统一的系统和方法。本文分析了中国目前的疾病状况，并讨论了中国在全球防治结核病和糖尿病流行的战斗中可能发挥的作用。
